Prazosin—an α-1 adrenergic receptor antagonist—may be able to help people with alcohol use disorder reduce heavy drinking over time. This is according to a study by Tracy Simpson, PhD, Andrew Saxon, MD, Cynthia Stappenbeck, PhD, Murray Raskind, MD, and colleagues that was published last week in the American Journal of Psychiatry.